-
1
المؤلفون: Andreas Engert, Carla J. de Boer, Sonja Kotoulek, Regina Aquino, Shobha Seetharam, Caly Chien, Max S. Topp, Vincent Ribrag, Franck Morschhauser, Bastian von Tresckow
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c7de90b064ae02712561e366675b9f
https://doi.org/10.1158/1078-0432.c.6522986.v1 -
2
المؤلفون: Andreas Engert, Carla J. de Boer, Sonja Kotoulek, Regina Aquino, Shobha Seetharam, Caly Chien, Max S. Topp, Vincent Ribrag, Franck Morschhauser, Bastian von Tresckow
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9f60b8285041359ca86445c83a175f
https://doi.org/10.1158/1078-0432.22455317.v1 -
3
المؤلفون: Caly Chien, Sonja Kotoulek, Shobha Seetharam, Regina Aquino, Andreas Engert, Franck Morschhauser, Max S. Topp, Carla de Boer, Bastian von Tresckow, Vincent Ribrag
المصدر: Clinical Cancer Research. 21:1843-1850
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Pyridines, Nausea, Antineoplastic Agents, Receptor, Macrophage Colony-Stimulating Factor, Pharmacology, Gastroenterology, Refractory, Pharmacokinetics, Internal medicine, Clinical endpoint, Refractory Hodgkin Lymphoma, Humans, Medicine, Dosing, Adverse effect, Protein Kinase Inhibitors, Aged, Neoplasm Staging, business.industry, Imidazoles, Middle Aged, Hodgkin Disease, Treatment Outcome, Oncology, Pharmacodynamics, Retreatment, Female, Neoplasm Recurrence, Local, medicine.symptom, business, Biomarkers
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613b4984215dd87102d3b0af1415b1ce
https://doi.org/10.1158/1078-0432.ccr-14-1845 -
4
المؤلفون: Vincent Ribrag, Franck Morschhauser, Regina Aquino, Sonja Kotoulek, Caly Chien, Bastian von Tresckow, Imran Khan, Max S. Topp, Shobha Seetharam, Andreas Engert, Carla de Boer
المصدر: Blood. 122:1812-1812
مصطلحات موضوعية: medicine.medical_specialty, Nausea, business.industry, Surrogate endpoint, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Internal medicine, Pharmacodynamics, Cohort, medicine, Clinical endpoint, Dosing, medicine.symptom, business, Adverse effect, Progressive disease
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2bac51837312b0c15f2225491ddccb0a
https://doi.org/10.1182/blood.v122.21.1812.1812